Ziconotide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ziconotide. Educational only — not medical advice.
Labeled uses
PRIALT (ziconotide) solution, intrathecal infusion is indicated for the management of severe chronic pain in adult patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine.
Source: FDA labeling via NIH DailyMed (set b025d8ed…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.